These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 3116095)
1. The expression and regulation of c-myb transcription in B6/lpr Lyt-2-, L3T4-T lymphocytes. Yokota S; Yuan D; Katagiri T; Eisenberg RA; Cohen PL; Ting JP J Immunol; 1987 Oct; 139(8):2810-7. PubMed ID: 3116095 [TBL] [Abstract][Full Text] [Related]
2. Molecular basis of elevated c-myb expression in the abnormal L3T4-, Lyt-2- T lymphocytes of autoimmune mice. Evans JL; Boyle WJ; Ting JP J Immunol; 1987 Nov; 139(10):3497-505. PubMed ID: 3316384 [TBL] [Abstract][Full Text] [Related]
3. Two different molecular pathways account for low IL-2 receptor and c-myc mRNA expression by lpr Lyt-2- L3T4- T cells. Katagiri K; Katagiri T; Yokota S; Eisenberg RA; Cohen PL; Ting JP J Immunol; 1988 Sep; 141(6):2145-52. PubMed ID: 3139753 [TBL] [Abstract][Full Text] [Related]
4. Abnormal expression of T cell receptor genes in Lyt-2- L3T4- lymphocytes of lpr mice: comparison with normal immature thymocytes. Miescher GC; Budd RC; Lees RK; MacDonald HR J Immunol; 1987 Mar; 138(6):1959-67. PubMed ID: 3102607 [TBL] [Abstract][Full Text] [Related]
5. Oncogene expression in autoimmune mice. Mountz JD; Mushinski JF; Mark GE; Steinberg AD J Mol Cell Immunol; 1985; 2(3):121-31. PubMed ID: 3916923 [TBL] [Abstract][Full Text] [Related]
6. Studies of c-myb gene regulation in MRL-lpr/lpr mice. Identification of a 5' c-myb nuclear protein binding site and high levels of binding factors in nuclear extracts of lpr/lpr lymph node cells. Mountz JD; Steinberg AD J Immunol; 1989 Jan; 142(1):328-35. PubMed ID: 2642505 [TBL] [Abstract][Full Text] [Related]
7. Growth and differentiation in vitro of the accumulating Lyt-2-/L3T4- subset in lpr mice. Budd RC; MacDonald HR; Lowenthal JW; Davignon JL; Izui S; Cerottini JC J Immunol; 1985 Dec; 135(6):3704-11. PubMed ID: 3934265 [TBL] [Abstract][Full Text] [Related]
8. Interleukin 2 responses of lpr and normal L3T4-/Lyt-2- T cells induced by TPA plus A23187. Katagiri K; Katagiri T; Eisenberg RA; Ting J; Cohen PL J Immunol; 1987 Jan; 138(1):149-56. PubMed ID: 3097142 [TBL] [Abstract][Full Text] [Related]
9. Selective production of interleukin 3 (IL3) and granulocyte-macrophage colony-stimulating factor (GM-CSF) in vitro by murine L3T4+ T cells: lack of spontaneous IL3 and GM-CSF production by Ly-2-/L3T4- lpr subset. Davignon JL; Kimoto M; Kindler V; De Kossodo S; Vassalli P; Izui S Eur J Immunol; 1988 Sep; 18(9):1367-72. PubMed ID: 3139430 [TBL] [Abstract][Full Text] [Related]
10. Distinct signals are required for proliferation and lymphokine gene expression in murine T cell clones. Heckford SE; Gelmann EP; Agnor CL; Jacobson S; Zinn S; Matis LA J Immunol; 1986 Dec; 137(11):3652-63. PubMed ID: 3097128 [TBL] [Abstract][Full Text] [Related]
11. Functional analysis of T cell subsets from mice bearing the lpr gene. Davignon JL; Budd RC; Ceredig R; Piguet PF; MacDonald HR; Cerottini JC; Vassalli P; Izui S J Immunol; 1985 Oct; 135(4):2423-8. PubMed ID: 3928747 [TBL] [Abstract][Full Text] [Related]
12. CS-A therapy in MRL-lpr/lpr mice: amelioration of immunopathology despite autoantibody production. Mountz JD; Smith HR; Wilder RL; Reeves JP; Steinberg AD J Immunol; 1987 Jan; 138(1):157-63. PubMed ID: 3537128 [TBL] [Abstract][Full Text] [Related]
13. Cultured Lyt-2- L3T4- T lymphocytes from normal thymus or lpr mice express a broad spectrum of cytolytic activity. Budd RC; Cerottini JC; MacDonald HR J Immunol; 1986 Dec; 137(12):3734-41. PubMed ID: 3491147 [TBL] [Abstract][Full Text] [Related]
14. Stimulation of murine T cells via the Ly-6C antigen: lack of proliferative response in aberrant T cells from lpr/lpr and gld/gld mice despite high Ly-6C antigen expression. Dumont FJ J Immunol; 1987 Jun; 138(12):4106-13. PubMed ID: 2438334 [TBL] [Abstract][Full Text] [Related]
15. Autoreactivity accelerates the development of autoimmunity and lymphoproliferation in MRL/Mp-lpr/lpr mice. Weston KM; Yeh ET; Sy MS J Immunol; 1987 Aug; 139(3):734-42. PubMed ID: 3110283 [TBL] [Abstract][Full Text] [Related]
16. Aberrant expression of the very early activation antigen on MRL/Mp-lpr/lpr lymphocytes. Sobel ES; Yokoyama WM; Shevach EM; Eisenberg RA; Cohen PL J Immunol; 1993 Jan; 150(2):673-82. PubMed ID: 8380429 [TBL] [Abstract][Full Text] [Related]
17. Reversal of hyporesponsiveness in lpr CD4-CD8- T cells is achieved by induction of cell cycling and normalization of CD2 and p59fyn expression. Clements JL; Wolfe J; Cooper SM; Budd RC Eur J Immunol; 1994 Mar; 24(3):558-65. PubMed ID: 7510235 [TBL] [Abstract][Full Text] [Related]
18. Phorbol ester-mediated inhibition of growth and regulation of proto-oncogene expression in the human T cell leukemia line JURKAT. Makover D; Cuddy M; Yum S; Bradley K; Alpers J; Sukhatme V; Reed JC Oncogene; 1991 Mar; 6(3):455-60. PubMed ID: 2011401 [TBL] [Abstract][Full Text] [Related]
19. Differential expression of nuclear proto-oncogenes in T cells triggered with mitogenic and nonmitogenic T3 and T11 activation signals. Shipp MA; Reinherz EL J Immunol; 1987 Oct; 139(7):2143-8. PubMed ID: 2821108 [TBL] [Abstract][Full Text] [Related]
20. Multiple mechanisms of regulation of the human c-myb gene during myelomonocytic differentiation. Boise LH; Gorse KM; Westin EH Oncogene; 1992 Sep; 7(9):1817-25. PubMed ID: 1323820 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]